Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve Audited Financial Results for ....
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has informed BSE that its Board of Directors will meet on 28th May 2025 to consider and approve the audited financial results for the quarter and full year ended 31st March 2025. The notice also covers other routine items of business and related matters. Additionally, the company has announced that the trading window for employees, connected persons, and their immediate relatives will be closed from 13th May 2025 until 48 hours after the financial results are declared, in line with insider trading regulations. No actual financial numbers have been disclosed in this filing, as it is a procedural advance notice.
This is a routine regulatory intimation with no immediate impact on shareholders. Investors should watch for the actual results on 28th May 2025, which will provide a clearer picture of the company's FY25 performance.